Compare MXCT & DWSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MXCT | DWSN |
|---|---|---|
| Founded | 1999 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.0M | 137.3M |
| IPO Year | 2021 | 1995 |
| Metric | MXCT | DWSN |
|---|---|---|
| Price | $1.19 | $5.79 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 93.9K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | N/A | ★ 0.25 |
| Revenue | $33,026,000.00 | ★ $145,773,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.50 | N/A |
| P/E Ratio | ★ N/A | $23.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $1.27 |
| 52 Week High | $2.37 | $6.25 |
| Indicator | MXCT | DWSN |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 69.51 |
| Support Level | $1.08 | $1.75 |
| Resistance Level | $1.30 | N/A |
| Average True Range (ATR) | 0.07 | 0.43 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 46.40 | 83.02 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.